The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]

Files in this item

Files Size Format View
By request of the author, access to this item is restricted. See below for more details.

The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines [Editorial]

Griffin, Brendan T.; Dressman, Jennifer B.
Date: 2019-03-03
Copyright: © 2019, Royal Pharmaceutical Society of Great Britain. Published by John Wiley & Sons, Inc. All rights reserved. This is the peer reviewed version of the following article: Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083, which has been published in final form at https://doi.org/10.1111/jphp.13083. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Related: https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.13083
Full text restriction information: Access to this article is restricted until 12 months after publication by request of the publisher.
Restriction lift date: 2020-03-03
Citation: Griffin, B. T. and Dressman, J. B. (2019) 'The PEARRL reviews - innovative drug development strategies tailored to facilitate earlier access to new oral medicines', Journal of Pharmacy and Pharmacology, 71(4), pp. 439-440. doi:10.1111/jphp.13083
Published Version: 10.1111/jphp.13083

Show full item record

This item appears in the following Collection(s)

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement